|
|
||||||||
|
Interact CardioVasc Thorac Surg 2009;8:654-660. doi:10.1510/icvts.2008.200386 © 2009 European Association of Cardio-Thoracic Surgery
External iliac artery pseudoaneurysm complicating renal transplantation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract |
|---|
|
|
|---|
Key Words: Iliac artery; Pseudoaneurysm; Renal allograft; Endovascular repair; Open repair
| 1. Introduction |
|---|
|
|
|---|
Due to the few small series of patients and isolated case reports described in current literature, the occurrence and treatment of this potentially life-threatening complication, its etiology, indications for repair, management options and prognosis remain very controversial.
A defective suture technique [5] or arterial dehiscence caused by local infection [6] certainly plays a role in iliac pseudoaneurysm formation in renal transplant patients, while immunogenic factors such chronic rejection, which has been hypothesized [7, 8] have yet to be proven. These pseudoaneurysms are usually asymptomatic yet can cause fever and anemia [9], compression of adjacent structures [10], renal dysfunction and graft loss [1], or even precipitate a life-threatening hemorrhage due to acute rupture [3, 7, 8, 10, 11]. Therapeutic options include conventional open repair (OR) [7, 10], endovascular repair (EVR) [8, 12–14], and more recently, ultrasound-guided percutaneous thrombin injection [15] (USG-PT). Herein we will report on our personal experience with 11 pseudoaneurysm patients in order to assess the causes, indications for repair, and the early and mid-term results of OR and EVR performed for the treatment of this challenging complication of renal transplantation.
| 2. Materials and methods |
|---|
|
|
|---|
Patient data collected were demographics, date of transplant, rejection episodes, date and surgical nephrectomy technique, date of pseudoaneurysm diagnosis, pseudoaneurysm site and size, type of anesthesia, postoperative length of stay (LOS), perioperative mortality and morbidity, survival outcome, and cause of death. In the last 12 years endovascular treatment was offered to all anatomically suitable patients. Intraoperative cultures of the vascular bed and samples of the pseudoaneurysm and donor renal artery were obtained from all surgical cases. Sections were embedded in paraffin and stained with either hematoxylin and eosin (H and E), and a combination of Masson's trichrome and Weigert's elastic stain. Because immunohistochemical examination was not feasible at that time, paraffin blocks were collected over a 25-year study period, and additional transverse sections were recently obtained and stained immunohistochemically (PAP-method), using the following cell type-specific antibodies: CD20 for B lymphocytes, CD3 for T lymphocytes, CD4 for T helper and CD8 for T suppressor lymphocytes (Dako, Glostrup, Denmark).
Patients in both groups were followed by clinical investigation and Duplex scan at 1, 6, and 12 months, and annually thereafter for three years. Three patients in the Group 1 and two in the Group 2 were subsequently lost to follow-up. The latter three patients in the Group 2 are still followed-up at the time of this review.
| 3. Results |
|---|
|
|
|---|
|
|
|
|
In the last 12 years, three pseudoaneurysms (1 in Group 1, 2 in Group 2) were treated with a stent-graft deployment. Passager grafts (Meadox, Oakland, NJ) were placed in two patients, and Hemobahn graft (W.L. Gore and Associates, Flagstaff, AZ) in one. The procedures were performed via an ipsilateral femoral cut down under local anesthesia; the covered stents used were 8–10 mm in diameter and 50 or 60 mm in length.
In one patient, two endoprostheses were implanted to exclude a pseudoaneurysm complicating extracapsular transplant nephrectomy, which was most likely caused by a clip falling off the donor renal artery stump (Fig. 3). Another patient underwent a two-stage procedure for treatment of a ruptured pseudoaneurysm, including stent-grafting followed by delayed surgical drainage of the hematoma and transplant nephrectomy.
|
The mean postoperative LOS for patients who underwent a one-stage procedure was 10.7 days (range 9–13 days) in Group 1 and 7.8 days (range 2–12 days) in Group 2 with the LOS being briefer in the EVR subgroup than the OR subgroup (2.5 days vs. 10.6 days).
The LOS for the last patient in Group 1 who received a two-stage procedure was 18 days due to a wound infection and dehiscence complicating transplant nephrectomy. Postoperative complications occurred in three patients in Group 1 and in two patients in Group 2 (Tables 1 and 2) leading to a morbidity rate of 60% and 33.3%, respectively. All the complications occurred in the OR subgroup (50%) while no complications resulted in the EVR subgroup. None of the patients suffered limb loss. One patient in Group 1 died of sepsis 10 days after OR, and no death occurred in Group 2 and in the EVR subgroup.
Intraoperative cultures of the vascular bed showed the presence of Candida albicans and E. coli in two febrile patients. Pathologic evaluation of the pseudoaneurysm specimens revealed marked fibrosis and varying degrees of fragmentation of elastic fibers. Out of the samples from donor renal arteries, three from the Group 1 patients (No. 1, 4, 5) and two from Group 2 patients (No. 2, 4) had histologic evidence of chronic rejection, with complete loss of endothelial cells, disruption of elastic fibers and fibrosis, endoluminal thrombosis, and immunohistochemical positive reaction with CD4 (Fig. 4).
|
| 4. Discussion |
|---|
|
|
|---|
Although intrarenal small aneurysms are reported in association with acute or chronic rejection, no experimental nor clinical data have suggested an immunological cause for extrarenal aneurysms in transplant patients. Our series shows evidence of chronic rejection, with presence of CD4 T-cell mediated rejection response, at level of donor renal artery in three patients presenting anastomotic pseudoaneurysm at an average interval of 6.3 months, and at level of renal artery stump in two presenting pseudoaneurysm at a median of 6.5 months after an extracapsular transplant nephrectomy. The indication for urgent graft removal in these two patients was the early occlusion of renal vessels while immunosuppression was progressively withdrawn upon the return of the patients to dialysis.
These data are similar to these shown of the clinical use of arterial allografts for limb salvage [16] or aortic aneurysm repair, as well as in the treatment of prosthetic graft infection [17], with frequent aneurysmal degeneration because of immunologic rejection. On the contrary, no allograft degradation was found in transplanted patients receiving immunosuppressive treatment [18].
The indications for pseudoaneurysm repair and treatment modalities are at present subject to debate.
In the absence of infection, asymptomatic small pseudoaneurysm can be managed conservatively with regular monitoring [2], while recent reports advocate that pseudoaneurysm presenting symptoms [10] with a size of 2.5 cm, and progressive enlargement and rupture need to be treated [7]. However, in one patient a mycotic aneurysm was treated conservatively with no complications during a 38-month follow-up [19].
Due to the presence of symptoms and pseudoaneurysms of a large diameter, all eleven of our transplanted patients underwent surgical or EVR of pseudoaneurysms and no patient was treated conservatively.
Another point to be mentioned is the need of nephrectomy in the majority of renal transplant patients affected with anastomotic pseudoaneurysm due to resistant rejection, function failure or infection. When not required, surgical resection with patch angioplasty [20] or reanastomosis [21] could save the allograft. Conversely, an interposition graft or extra-anatomic reconstruction following pseudoaneurysm excision leads to graft loss [3], unless a kidney autotransplantation when feasible.
During the surgical repair of an extrarenal pseudoaneurysm at the anastomotic site, all except one of our patients required a transplant nephrectomy due to irreversible rejection (2) or local infection (1), while the one patient received an allograft autotransplantation to maintain stable renal function.
At present, questions remain regarding the need of concomitant vascular reconstruction after surgical pseudoaneurysm excision. Eng et al. [3] reported no limb loss following external iliac artery ligation, while three out of 14 cases of the series of Gorey et al. [22] required subsequent elective reconstruction for claudication. Furthermore, an above-knee amputation was reported in a 25-year-old woman who developed foot ischemia three months after external iliac artery ligation [2].
In the case of critical leg ischemia following transplant nephrectomy with suspected local infection, an antibiotic impregnated prosthetic graft was preferred by Eng et al. [3] using an extra-anatomical route. Two febrile patients out of our study were infected and received simultaneous artery ligation and crossover femoral-femoral graft [6] using a polytetrafluoroethylene (PTFE) and a silver-coated polyester prosthesis, respectively. In the additional six patients who had no clinical suspicion of infection, we performed an interposition polyester grafting after pseudoaneurysm excision.
Of particular interest was the fact that all seven of our prosthetic grafts remained patent during an average follow-up of 52.5 months, with no evidence of stenosis, infection or pseudoaneurysm recurrence. As a result, we can recommend distal revascularization following aneurysmectomy.
During the past decade, EVR has evolved into the treatment of choice for both external iliac anastomotic pseudoaneurysm, with renal artery exclusion and subsequent transplant loss, and pseudoaneurysm following transplant nephrectomy [8, 11–13]. The procedure can be considered a valuable therapeutic option even in emergency situations [14]; adjunctive percutaneous drainage of retroperitoneal blood collection [12] or combined open surgical drainage and transplant nephrectomy may be required once a patient's condition is stabilized, as was the case in one of our patients presenting a ruptured iliac pseudoaneurysm who had undergone a successful two-stage procedure.
In contrast, Eng et al. [3] performed emergency surgical control of hemorrhage and simultaneous allograft nephrectomy in two patients with ruptured anastomotic pseudoaneurysms. One of the patients (50%) died from a secondary hemorrhage originating from the infected vascular stump. A successful placement of covered stents has also been reported for the treatment of pseudoaneurysms due to bacterial or fungal infection [13, 23], but Liapis et al. [24] described a Palmaz stent infection requiring open pseudoaneurysm excision and stent removal in an immunocompromised patient. During the last 12 years, we have performed stent-grafting in three renal transplant patients to exclude a pseudoaneurysm, but did not do so in febrile patients so as to minimize the risk of stent-graft infection. In our series, there were no post-EVR complications, no death at 30 days and the LOS (2.5 days vs. 10.6 days) was shorter.
More recently, successful USG-PT was described in the treatment of a large anastomotic pseudoaneurysm after failure of kidney transplant [15]. A combined USG-PT and covered stent placement across an end-to-end renal-to-internal iliac artery anastomosis was also used for the successful exclusion of a pseudoaneurysm. An adjunctive balloon dilatation of the branches of the transplant artery improved the intrarenal flow while preserving the kidney [23, 25].
The present study has found differences in 30-day results between Group 1 and Group 2 patients undergoing repair of a pseudoaneurysm. The incidence of postoperative complications was higher in patients who had anastomotic pseudoaneurysm repair, compared with those who received treatment for a pseudoaneurysm following transplant nephrectomy. In addition, the LOS tends to be longer in Group 1 than in Group 2 (10.7 days vs. 5.9 days, respectively).
The difference in early outcome could partly be explained by the coexistence of kidney rejection and immunosuppression causing a greater risk of infection and inadequate response to stress. The combined transplant nephrectomy could have contributed to the high morbidity and mortality rate of our Group 1 patients while it is unlikely that the difference in pseudoaneurysm size (7.1 cm vs. 5.9 cm) has influenced the outcome of the repair. Infection was the main cause of postoperative complications in our surgical patients and one patient died of sepsis.
This study is limited by its retrospective nature and the small group of 11 patients. Another potential limitation is that we included patients with both iliac anastomotic pseudoaneurysm in transplant patients and pseudoaneurysm following transplant nephrectomy. In addition, treatment options were substantially different during the second half of the study period. Therefore, long-term follow-up is not available.
In light of these limitations, our findings suggest that chronic rejection of donor renal artery may play a role in the development of 45% of the observed cases of pseudoaneurysms complicating kidney transplantation in our study. Though rare, the development of pseudoaneurysms at the donor renal-external iliac artery anastomosis results in high rates of transplant nephrectomy. The choice of OR or EVR in these pseudoaneurysms has yet to be fully delineated; nevertheless, EVR has resulted in a better early outcome with a shorter LOS. After pseudoaneurysm excision, arterial reconstruction is recommended to prevent lower limb ischemia. Long-term follow-up data are required to assess the overall durability of OR and EVR.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |